Tonix Pharmaceuticals announced upcoming oral and poster presentations at the American Transplant Congress regarding their TNX-1500 product candidate for preventing organ rejection.
AI Assistant
TONIX PHARMACEUTICALS HOLDING CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.